The personal genome-the future of personalised medicine?

The Lancet

Volumn 375, Issue 9725, 2010, Pages 1497-1498

  Samani, Nilesh J ^a,b   Tomaszewski, Maciej ^a,b   Schunkert, Heribert ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Leicester NIHR Biomedical Research Unit in Cardiovascular Disease   (United Kingdom)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ARTICLE; CANCER RISK; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FUNDING; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE;

EID: 77951547487     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60598-3     Document Type: Note

References (15)

1. Kan Y.W., and Dozy A.M. Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci USA 75 (1978) 5631-5635
2. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431 (2003) 931-945
3. International HapMap consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
4. Robson M., and Offit K. Management of an inherited predisposition to breast cancer. N Engl J Med 357 (2007) 154-162
5. The International Warfarin Pharmacogenetics Consortium. Estimation of warfarin dose with clinical and pharmacogenetic data. N Engl J Med 360 (2009) 753-764
6. Mega J.L., Close S.L., Wiviott S.D., et al. Cytochrome P-450 polymorphisms and response to clopidogrel. N Engl J Med 360 (2009) 354-362
7. The SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy-a genomewide study. N Engl J Med 359 (2008) 789-799
8. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 447 (2007) 661-678
9. National Human Genome Research Institute. A catalog of genome-wide association studies. http://www.genome.gov/GWAstudies (accessed April 21, 2010).
10. Waldman M. James Watson's genome sequenced at high speed. Nature 452 (2008) 788
11. Ashley E.A., Butte A.J., Wheeler M.T., et al. Clinical assessment incorporating a personal genome. Lancet 375 (2010) 1525-1535
12. Wheeler D.A., Srinivasan M., Egholm M., et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 452 (2008) 872-876
13. Kim J.I., Ju Y.S., Park H., et al. A highly annotated whole-genome sequence of a Korean individual. Nature 460 (2009) 1011-1015
14. Wray N.R., Goddard M.E., and Visscher P.M. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res 17 (2007) 1520-1528
15. Ormond K.E., Wheeler M.T., Hudgins L., et al. Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 10.1016/S0140-6736(10)60599-5 published online April 30.